MedPath

CUPRIC CHLORIDE

CUPRIC CHLORIDE INJECTION, USP – solution

Approved
Approval ID

daaa6f3a-148e-4f1c-bd44-bb2242145b88

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 16, 2019

Manufacturers
FDA

Exela Pharma Sciences, LLC

DUNS: 831274399

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

cupric chloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51754-0103
Application NumberANDA212071
Product Classification
M
Marketing Category
C73584
G
Generic Name
cupric chloride
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateMay 16, 2019
FDA Product Classification

INGREDIENTS (4)

CUPRIC CHLORIDEActive
Quantity: 0.4 mg in 1 mL
Code: S2QG84156O
Classification: ACTIM
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CUPRIC CHLORIDE - FDA Drug Approval Details